EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains

Oriol Ordi, Adela Saco, Núria Peñuelas, Odei Blanco-Irazuegui, Marta Del Pino, Núria Carreras-Dieguez, Lorena Marimon, Maria Teresa Rodrigo-Calvo, Alba Morató, Lia Sisuashvili, Mariona Bustamante, Adrià Cruells und 11 weitere

Modern Pathology · 2024-10 · 37 (10) · 100574

DOI: 10.1016/j.modpat.2024.100574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-10. Verfasst von Oriol Ordi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Facultat de Medicina i Ciències de la Salut, Department de Fonaments Clinics, Universitat de Barcelona, Barcelona, Spain; Barcelona Institute of Glob…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoma, Squamous Cell, Cyclin D1, Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCarcinoma, Squamous CellCyclin D1MutationTumor Suppressor Protein p53Vulvar NeoplasmsAdultAgedAged, 80 and overFemaleHumansMiddle AgedExome SequencingPapillomavirus InfectionsPrognosis

Stichwörter der Autor:innen

HPVgenomicsp53prognosissurvivalvulvar cancerwhole-exome sequencing

Substanzen

Biomarkers, TumorCCND1 protein, humanCyclin D1TP53 protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Facultat de Medicina i Ciències de la Salut, Department de Fonaments Clinics, Universitat de Barcelona, Barcelona, Spain; Barcelona Institute of Global Health (ISGlobal)-University of Barcelona, Barcelona, Spain.
  • Barcelona Institute of Global Health (ISGlobal)-University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital Clínic of Barcelona-University of Barcelona, Barcelona, Spain.
  • Barcelona Institute of Global Health (ISGlobal)-University of Barcelona, Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Department de Fonaments Clinics, Universitat de Barcelona, Barcelona, Spain.
  • Barcelona Institute of Global Health (ISGlobal)-University of Barcelona, Barcelona, Spain; Department of Obstetrics and Gynecology, Hospital Clínic - University of Barcelona, Barcelona, Spain.
  • Department of Obstetrics and Gynecology, Hospital Clínic - University of Barcelona, Barcelona, Spain.

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Ordi, O., Saco, A., Peñuelas, N., Blanco-Irazuegui, O., Pino, M. D., Carreras-Dieguez, N., Marimon, L., Rodrigo-Calvo, M. T., Morató, A., Sisuashvili, L., Bustamante, M., Cruells, A., Darecka, K., Vega, N., Alós, S., Trias, I., Fusté, P., Parra, G., Gut, M., …, & Rakislova, N. (2024). Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains. Modern Pathology, 37(10), 100574. https://doi.org/10.1016/j.modpat.2024.100574

Vancouver

Ordi O, Saco A, Peñuelas N, Blanco-Irazuegui O, Pino MD, Carreras-Dieguez N, et al. Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains. Modern Pathology. 2024;37(10):100574. doi:10.1016/j.modpat.2024.100574

BibTeX
@article{Ordi2024,
  author = {Ordi, Oriol and Saco, Adela and Peñuelas, Núria and Blanco-Irazuegui, Odei and Pino, Marta Del and Carreras-Dieguez, Núria and Marimon, Lorena and Rodrigo-Calvo, Maria Teresa and Morató, Alba and Sisuashvili, Lia and Bustamante, Mariona and Cruells, Adrià and Darecka, Katarzyna and Vega, Naiara and Alós, Silvia and Trias, Isabel and Fusté, Pere and Parra, Genis and Gut, Marta and Munmany, Meritxell and Torné, Aureli and Jares, Pedro and Rakislova, Natalia},
  title = {Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {10},
  pages = {100574},
  doi = {10.1016/j.modpat.2024.100574}
}
Kostenlos starten →